Founded in 2012, GHI is committed to the discovery, development and commercialization of targeted therapeutic agents for the treatment of several types of cancer and other disorders.
At GHI, we are passionate about using innovative ideas and cutting-edge technology to combat hard-to-treat diseases. We are a growing company, created and operated by scientists who perform focused research to develop novel therapeutics along an accelerated timeline. Our team consists of a diverse and driven group of biological scientists and clinicians experienced in research and discovery, product development, finance, and clinical affairs.
GHI is located in Norwood, MA, in close proximity to the Boston area scientific and pharmaceutical hub. Its operations are supported by laboratories and preclinical facilities designed for biopharmaceutical research and process development activities.